Conference call begins at 4:30 p.m. Eastern time today ANN ARBOR, Mich.--(BUSINESS WIRE)--$NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a...
Presentation will be at 11:00 a.m. ET on Monday, April 4, 2022BOHEMIA, NY / ACCESSWIRE / March 30, 2022 /...
PARIS, FRANCE / ACCESSWIRE / March 30, 2022 / Pharnext SA (FR0011191287 - ALPHA) (the "Company"), an advanced late-stage clinical...
Partnership is expected to fuel future growth initiatives and extensibility of mobile patient engagement platform ATLANTA--(BUSINESS WIRE)--Gozio Health, an industry-leading...
16 New U.S. and International Patents Issued over Past YearREDWOOD CITY, CA / ACCESSWIRE / March 30, 2022 / Avinger,...
LOS ANGELES, CA / ACCESSWIRE / March 30, 2022 / Marijuana Company of America, Inc. (OTC PINK:MCOA) ("the Company"), operates,...
Philips Ambient Experience and FlexVision display Philips Ambient Experience and FlexVision display for pediatric patients March 30, 2022 New solution...
Kalamazoo, Michigan, March 30, 2022 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday,...
SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life...
– CEO Remi Barbier to Discuss Q1 2022 Clinical and Corporate Updates – – Stakeholders Are Invited to Submit Questions...
The Boston-based virtual reality company helps seniors worldwide overcome social isolation and improve mental health through its social metaverse platformsBOSTON,...
Prof. Schroeder to advise on SCI-160 formulation development to enhance biological effect and extended effect duration TEL AVIV, Israel, March...
NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical...
Transformative Shockwave C2 Intravascular Lithotripsy Catheter Will Soon Be Available in One of the World’s Largest Coronary Intervention Markets SANTA...
VANCOUVER, Washington, March 30, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company...
Results anticipated in H2 2022NEWTON, Mass., March 30, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company...
SAN DIEGO, March 30, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that...
Exclusive License with Asahi Kasei Pharma to develop and commercialize Apraglutide in Japan includes $30 million upfront cash payment, eligibility...
STOUGHTON, Mass., March 30, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced the execution of a Master...
Ji’an, Jiangxi, China, March 30, 2022 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and...